Fasting glycemia: prognostic value in the immediate evolution of women with acute coronary síndrome
DOI:
https://doi.org/10.56294/hl2023198Keywords:
Acute coronary syndrome, fasting glycemia, cardiovascular complicationsAbstract
Ischemic heart disease is one of the leading causes of death in the world and in Cuba, with a significant increase in women. An observational, descriptive, cross-sectional study was carried out with the aim of evaluating the prognostic value of fasting glycemia determined in the first 24 hours of admission in women with a diagnosis of acute coronary syndrome (ACS) hospitalized in the coronary service of the Carlos J. Finlay HMC during 2015-2017. The universe consisted of 250 women over 20 years of age with a diagnosis of ACS and the sample consisted of 224 patients. Two groups were formed to compare each other: study group (≥6.11 mmol/L) with high fasting glucose value and control group (<6.11 mmol/L) with normal value. The mean glycemia value was higher in the study group being statistically significant (p < 0.000001). Age did not show significant difference between groups. HT (p<0.007), smoking (p<0.05) and ACS (p<0.004) in any of their clinical variants were statistically significant variables. Death as a complication was present in only 15 patients in the study group, representing 24.1% of deaths. There were no significant statistical differences in terms of coronary angiography results, since not all patients with ACS presented indications for this study.
Conclusions: The results of the study suggest that an elevated baseline fasting glycemia on admission in female patients diagnosed with ACS is a predictor of risk of death and complications during the hospital phase.
References
1. Espinosa Brito A, Ordóñez García PO. Necesidad de integración de salubristas, epidemiólogos y clínicos en la atención de pacientes con enfermedades crónicas. [en línea]. 2010 [Citado 2015 Sep. 20]; 36(3). Disponible en: http://www.bvs.sld.cu/revistas/spu/vol_36_03_10/spu11310.htm
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. [en línea]. 2010 [citado 2015 sep. 20]; 32(suppl 1): [Aprox.5p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613584/
3. World Health Organization. World Health Report 1997: Conquering, Suffering, Enriching Humanity. Geneva. WHO; 1997.
4. Lanas F, Avezum A, Bautista LE, Díaz R, Luna M, Islam S, et al. Risk Factors for Acute Myocardial Infarction in Latin America. Circulation. 2010; 115: 1067-107.
5. Ramírez Rodríguez M., Debs Pérez G. El problema de la Cardiopatía Isquémica en Cuba. RESUMED. 2001; 14(4):160-1.
6. MINSAP. Anuario Estadístico 2010. Dirección Nacional de Estadística, Cuba; 2010: 26-78.
7. Braunwald E. Braunwald Tratado de cardiología. Texto de medicina cardiovascular.10ma ed. España: Elsevier; 2016. p.1- 20.
8. Delcán Domínguez JL, García García J, Moreno Gómez R, Vegazo García O, Pérez David E, Serrano Sánchez JA. Cardiopatía Isquémica. Servicio de Cardiología. HOSPITAL GENERAL UNIVERSITARIO. GREGORIO MARAÑÓN. MADRID; 1999.
9. Martínez-Gómeza D, Eisenmannc JC, Gómez-Martíneza S, Vesesa A, Marcosa A, Veiga OL. Sedentarismo, adiposidad y factores de riesgo cardiovascular. Rev Esp Cardiol. 2010; 63(3):277-85.
10. Lanas F, Avezum A, Bautista LE, Díaz R, Luna M, Islam S, et al. Risk Factors for Acute Myocardial Infarction in Latin America. Circulation. 2010; 115: 1067-107.
11. Arikanoglu A, Yucel Y, Acar A, Cevik MU, Akil E, Varol S. The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients. Eur Rev Med Pharmacol Sci. 2013; 17:1774-7.
12. Kannel WB, McGee DL. Diabetes and cardiovascular risk factor: the Framingham study. Circulation. 1979; 59:8-13.
13. American Diabetes Association. Standards of Medical Care in Diabetes. The journal of clinical and applied research and education. [en línea] January 2016 [citado 2017 sep. 20]; 39(Suppl1): [120p.]. Disponible en: http://www.healthmonix.com/ADAWebcastSOC2016/common/files/2016SofC.pdf
14. Abu-Assi E, García-Acuña JM, Peña-Gil C, González-Juanatey JR. Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. Rev Esp Cardiol 2010; 63:640-8.
15. Fácila Rubio L. Importancia del control de la glucemia durante el síndrome coronario agudo. Servicio de Cardiología. Consorcio Hospital General de Valencia; 2014. p.1 -2.
16. Monteiro S, Monteiro P, Gonçalves F, Freitas M, Providência L. Hyperglycaemia at admission in acute coronary syndrome patients: prognostic value in diabetics and non-diabetics. Eur J Cardio-vasc Prev Rehabil. 2010; 17(2):155-9.
17. Munarriz A, Almansa I, Martínez Basterra J, Uribe-Echeberría. Síndrome Coronario Agudo. En: García Mouriz MA, Fernández B, editores. Libro electrónico de temas de urgencia; 2013.
18. Solla I, Bermbibre L, Freire J. Actualización de “ABCDE en Urgencias Extrahospitalarias” Manejo del Síndrome coronario agudo en Urgencias de Atención Primaria. Atención Primaria. 2011; (18): 49-55.
19. Gelpi RJ, Donato M. Fisiopatología cardiovascular. Editorial corpus; 2010.p. 49-50.
20. Olivera Peña L. Síndrome coronario agudo en la Mujer. Diferencias de Género. Granada: Editorial: Universidad de Granada; 2011.
21. Sancho Cantus D, Solano Ruiz MC. La cardiopatía isquémica en la mujer. Rev. Latino-Am. Enfermagem. [en línea] sep.-oct. 2011 [citado 2017 sep. 20]; 19(5):[8 p]. Disponible en: http://www.scielo.br/pdf/rlae/v19n6/es_25.pdf
22. McSweeney J, Cody M, Crane P. Do you Know them when you see them? Women’s prodromal and acute symptoms of myocardical infraction. J Cardiovasc Nurs. 2011;15(3):26-38.
23. Sancho Cantus D, Romero Sánchez J, Pastor Montero S, Martínez Sabater A, Sánchez Esteban B. Atención integral a la mujer con cardiopatía isquémica tras el alta hospitalaria. Biblioteca Lascasas. 2010; 6(2).
24. Alfonso F, Bermejo J, Segovia J. Enfermedades cardiovasculares en la mujer: ¿por qué ahora? Rev Esp Cardiol. 2012; 59(3):259-63.
25. Ibanez B, James S, Agew S, Antunes MJ, Bucciarelli-Ducci C. Bueno Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. [en línea] 2017 [citado 2017 sep. 20]; 70: [6p.].
26. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M. Andreotti Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol. 2015; 68:1061-7.
27. Garadah TS, Kassab S, Al-Shboul QM, Alawadi A. The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome. Clin Med Cardiol. 2009; 3:29-36.
28. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Del Pinto M, Repaci S, et al. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and metaanalysis. Curr Diabetes Rev. 2010;6(2):102-10.
29. Garadah TS, Kassab S, Al-Shboul QM, Alawadi A. The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome. Clin Med Cardiol. 2009; 3:29-36.
30. Rocha S, Nabais S, Magalhães S, Salgado A, Azevedo P, Marques J, et al. Admission glycemia: a predictor of death after acute coronary syndrome in nondiabetic patients? Rev Port Cardiol. 2010; 26(12):1367-77.
31. Vivas D, García-Rubira JC, González-Ferrer JJ, Núñez-Gil I, Prado N, Fernández-Ortiz A, et al. Valor pronóstico de la primera glucemia en ayunas en comparación con la glucemia al ingreso en pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2010; 61(5):458-64.
32. Goyal A, Mahaffey K, Garg J, Nicolau J, Hochman J, Weaver et al; Prognostic significance of the change in glucose level in the fist 24 h after acute myocardial infarction: results from the Cardinal study; European Heart Journal. 2006; 27: 1289- 12 97
33. Cerda J, Cifuentes L. Uso de tests diagnósticos en la práctica clínica (Parte 1 y 2). Análisis de las propiedades de un test diagnóstico. Rev Chil Infectol 2010
Published
Issue
Section
License
Copyright (c) 2023 Diego Rafael Miló González, Liz Odelnis Cruz Rodríguez, Emilio Luis Morales Jiménez (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
